Long versus short-term opioid therapy for fibromyalgia syndrome and risk of depression, sleep disorders and suicidal ideation: a population-based, propensity-weighted cohort study
These findings suggest that continued opioid use for 90 days or more may aggravate depression and sleep problems in patients with FMS when compared with patterns of short-term treatment.
Authors
- Aníbal García‐Sempere (ORCID: https://orcid.org/0000-0002-4313-3976)
- Salvador Peiró (ORCID: https://orcid.org/0000-0002-3902-569X)
- F. Gonzalez Llopis
- Isabel Hurtado (ORCID: https://orcid.org/0000-0002-8475-8112)
- Gabriel Sanfélix‐Gimeno (ORCID: https://orcid.org/0000-0001-7098-4576)
- Clara Liliana Rodríguez-Bernal (ORCID: https://orcid.org/0000-0003-2617-8635)
- Celia Robles (ORCID: https://orcid.org/0000-0002-3978-7336)
- Francisco Sánchez
Institutions
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Red de Investigación en Actividades Preventivas y Promoción de la Salud (ES)
Publication Details
- Journal
- RMD Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1136/rmdopen-2024-004466
- Citations
- 9
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 3.47
Funders
- Ministerio de Ciencia, Innovación y Universidades
- European Commission
- Instituto de Salud Carlos III